Ethylene

Ethylene

SCHEMBL8002075

C=C.CCC1CCCCC1

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
SHBG P04278 1/20 0.38
CHRM5 P08912 2/20 0.36
ADRA2C P18825 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM4 P08173 1/20 0.36
CHRM1 P11229 1/20 0.36
ACHE P22303 1/20 0.36
SIGMAR1 Q99720 3/20 0.34
ADH1B P00325 1/20 0.33
ADH1C P00326 1/20 0.33
ADH1A P07327 1/20 0.33
ADH4 P08319 1/20 0.33
ADH7 P40394 1/20 0.33
HTT P42858 1/20 0.32
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cyclopentane SCHEMBL9453150 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL18078965 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL1437788 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
Cyclohexane SCHEMBL10836383 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL18481332 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL25446788 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL3032796 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL4576671 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
Cyclohexane SCHEMBL8731700 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2
SCHEMBL431459 0.94 CYP1A2 (0.52) CYP1A2SHBGCHRM5ADRA2CCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6294573-B1 FOR THERAPY RHEUMATOID ARTHRITIS, OSTEOARTHRITIS, OSTEOPENIAS SUCH AS OSTEOPOROSIS, PERIODONTITIS, GINGIVITIS, CORNEAL, EPIDERMAL OR GASTRIC ULCERATION, AND TUMOR GROWTH AND METASTASIS OR INVASION ABBOTT LABORATORIES 2001-09-25 US disclosed